Hypovitaminosis D in Neurocritical Patients

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 274 participants.

Also called NCT02881957

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 274 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02881957
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02881957. Randomized; quadruple masking; primary purpose treatment. Start 2016-10-10 (actual); primary completion 2018-10-10 (actual). Results posted on 2020-08-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hypovitaminosis D in Neurocritical Patients
Condition
Craniocerebral Trauma
Condition
Intracranial Aneurysm
Condition
Brain Neoplasms
Condition
Spinal Cord Injuries
Condition
Seizures
Condition
Meningitis
Condition
Stroke
Condition
Intracranial Hemorrhages
Condition
Critical Illness
Condition
Vitamin d Deficiency
Intervention (Drug)
Cholecalciferol
Intervention (Other)
Placebo
Lead sponsor
University of Utah (class: other)

Record details

Record id
cardio:ct-nct02881957
Content hash
cec0a03b3bdc28df353770297b165ae96949b749a156c90ccf326ceabea55776